CD30 expression in cutaneous B-cell lymphomas.
Olabisi Afolayan-OloyeLili ZhaoTrilokraj TejasviMay P ChanKelly L HarmsDouglas R FullenRyan A WilcoxAlexandra C HristovPublished in: Journal of cutaneous pathology (2023)
CD30 may be expressed in CBCL, possibly causing diagnostic confusion. CD30 expression was most commonly identified in PCFCL and is associated with favorable clinical features. In cases with strong and diffuse expression, CD30 could be a therapeutic target.